Indications
Open Access TIMES Journals
Login
Register
Login
Register
Indications
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Open Access TIMES Journals
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Gynecology · Urology
Case Reports
Expert Opinions
Webinar
Faculty
Homepage
>
Gynecology · Urology
>
Articles
Bevacizumab in cervical cancer: a step forward for survival
HPV and Gynecologic Cancer
Share:
Related content
HPV and Gynecologic Cancer
No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study
Eur J Cancer.
Alfonzo E, Wallin E, Ekdahl L, Staf C, Rådestad AF, Reynisson P, Stålberg K, Falconer H, Persson J, Dahm-Kähler P
doi: 10.1016/j.ejca.
HPV and Gynecologic Cancer
Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer
Obstet Gynecol.
Sia TY, Chen L, Melamed A, Tergas AI, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD
doi: 10.1097/AOG.0000000000003523.
HPV and Gynecologic Cancer
Genetic variations in human papillomavirus and cervical cancer outcomes
Int J Cancer.
Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ
doi: 10.1002/ijc.32038.
HPV and Gynecologic Cancer
Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study
Lancet Oncol.
Höckel M, Wolf B, Schmidt K, Mende M, Aktas B, Kimmig R, Dornhöfer N, Horn LC
doi: 10.1016/S1470-2045(19)30389-4.
HPV and Gynecologic Cancer
Validation of the 2018 FIGO cervical cancer staging system
Gynecol Oncol.
Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M
doi: 10.1016/j.ygyno.2018.10.026.
HPV and Gynecologic Cancer
Does HPV status influence survival after vulvar cancer?
Int J Cancer.
Rasmussen CL, Sand FL, Hoffmann Frederiksen M, Kaae Andersen K, Kjaer SK
doi: 10.1002/ijc.31139.
HPV and Gynecologic Cancer
Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer
Gynecol Oncol.
Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH
doi: 10.1016/j.ygyno.2017.10.017.
HPV and Gynecologic Cancer
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis
Lancet HIV.
Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P; ART and HPV Review Group
doi: 10.1016/
HPV and Gynecologic Cancer
Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
Br J Cancer.
Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J
doi: 10.1038/s41416-018-0053-6.